Multiple Sclerosis (MS) is highly heterogeneous in clinical and imaging presentation and key pathophysiological processes of inflammation and neurodegeneration. Hence, establishing an accurate clinical picture of disease activity and progression in individual patients is a core challenge requiring knowledge and integration of the key elements driving the disease and its temporal evolution. Essential elements are the spectrum of neurological manifestation, imaging markers of disease burden, patient age, disease duration, initial symptoms, previous treatment response, and to some extent, cerebrospinal fluid or blood biomarkers. The highly complex interplay of these many different features requires a high level of experience by the clinician.